Bio-Rad Laboratories (BIO) Short-term Investments (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Short-term Investments data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Short-term Investments fell 7.16% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 7.16% YoY) and the FY2025 annual result came in at $1.0 billion, down 14.07% from the prior year.
• Short-term Investments rose to $1.1 billion in Q1 2026 per BIO's latest filing, from $1.0 billion in the prior quarter.
• Across five years, Short-term Investments topped out at $1.3 billion in Q2 2023 and bottomed at $5.6 million in Q2 2022.
• The 5-year median for Short-term Investments is $1.0 billion (2025), against an average of $604.0 million.
• Peak annual rise in Short-term Investments reached 23869.15% in 2023, while the deepest fall reached 99.56% in 2023.
• Tracing BIO's Short-term Investments over 5 years: stood at $5.6 million in 2022, then changed by 0.0% to $5.6 million in 2023, then surged by 20907.14% to $1.2 billion in 2024, then declined by 14.07% to $1.0 billion in 2025, then rose by 4.61% to $1.1 billion in 2026.
• Per Business Quant, the three latest BIO Short-term Investments figures stand at $1.1 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025).

Peer Comparison